Be Aware Otezla May Be Safer Than Methotrexate for Plaque Psoriasis

You'll see two new treatment options for moderate to severe plaque psoriasis, Otezla (apremilast) and Cosentyx (secukinumab).

About 20% of psoriasis patients need systemic meds added to topicals.

Be aware of the extra interactions, side effects, and monitoring.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote